Latest Articles
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test - MedCity News
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test MedCity News
Published: July 2, 2025, 8:17 p.m.
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis - Frontiers
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis Frontiers
Published: July 2, 2025, 4:08 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener
Published: July 2, 2025, 12:51 p.m.
Organon axes 'biggest potential opportunity' after flunking phase 2 trial - Fierce Biotech
Organon axes 'biggest potential opportunity' after flunking phase 2 trial Fierce Biotech
Published: July 2, 2025, 12:43 p.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
Endometrial Cancer Cases Rising Among Young Women - Bernama
Endometrial Cancer Cases Rising Among Young Women Bernama
Published: July 1, 2025, 2:01 p.m.
Gastric Ectopic Pancreatic Ductal Adenocarcinoma Coexisted with Endometriosis Mimick Advanced Disease: A Case Report and literature review - Frontiers
Gastric Ectopic Pancreatic Ductal Adenocarcinoma Coexisted with Endometriosis Mimick Advanced Disease: A Case Report and literature review Frontiers
Published: July 1, 2025, 1:44 p.m.
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment.
Endometriosis is a common gynecological condition that usually affects women during their reproductive years. The main goal of this narrative review is to understand the role of the innate and …
Published: July 1, 2025, midnight
Unraveling the Contribution of Estrobolome Alterations to Endometriosis Pathogenesis.
Endometriosis (EMS) is a long-term inflammatory disease. It represents one of the most prevalent gynecological conditions, impacting an estimated 5% of reproductive women. Therefore, endometriosis contributes to substantial worldwide health …
Published: July 1, 2025, midnight
Link copied to clipboard!